Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Expert Reviews in Molecular Medicine

• Publication date

  2018-01-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/erm.2017.12PMID 29343314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs

  2017cited by this paper
• Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients

  2017cited by this paper
• Evaluation of Digital PCR as a Technique for Monitoring Acute Rejection in Kidney Transplantation

  2017cited by this paper
• Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA.

  2017cited by this paper
• Cell-Free DNA and Active Rejection in Kidney Allografts.

  2017cited by this paper
• Mitochondrial DNA is Released in Urine of SIRS Patients With Acute Kidney Injury and Correlates With Severity of Renal Dysfunction

  2017cited by this paper
• Peritoneal Cell-free DNA: an innovative method for determining acute cell damage in peritoneal membrane and for monitoring the recovery process after peritonitis

  2016cited by this paper
• Urinary Mitochondrial DNA Copy Number Identifies Chronic Renal Injury in Hypertensive Patients

  2016cited by this paper
• At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases

  2016cited by this paper
• Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients.

  2016cited by this paper
• Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

  2016cited by this paper
• A novel method for high-throughput detection and quantification of neutrophil extracellular traps reveals ROS-independent NET release with immune complexes.

  2016cited by this paper
• A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function

  2016cited by this paper
• Role of Mitochondrial DNA in Septic AKI via Toll-Like Receptor 9.

  2016cited by this paper
• Urinary Biomarkers Indicative of Apoptosis and Acute Kidney Injury in the Critically Ill

  2016cited by this paper
• Plasma Mitochondrial DNA Level is a Prognostic Marker in Peritoneal Dialysis Patients

  2016cited by this paper
• The role of neutrophils and NETosis in autoimmune and renal diseases

  2016cited by this paper
• Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome

  2016cited by this paper
• Myeloperoxidase anti‐neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti‐neutrophil cytoplasmic antibody‐associated microscopic polyangiitis

  2016cited by this paper
• Renoprotective Effects of DNAse-I Treatment in a Rat Model of Ischemia/Reperfusion-Induced Acute Kidney Injury

  2016cited by this paper
• Cell‐Free DNA: An Upcoming Biomarker in Transplantation

  2015cited by this paper
• Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation.

  2015cited by this paper
• Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals.

  2015cited by this paper
• Bisulfite Conversion of DNA from Tissues, Cell Lines, Buffy Coat, FFPE Tissues, Microdissected Cells, Swabs, Sputum, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine.

  2015cited by this paper
• TLR9 Mediates Remote Liver Injury following Severe Renal Ischemia Reperfusion

  2015cited by this paper
• Extracellular, but not intracellular HMGB1, facilitates self-DNA induced macrophage activation via promoting DNA accumulation in endosomes and contributes to the pathogenesis of lupus nephritis.

  2015cited by this paper
• Importance of low serum DNase I activity and polyspecific anti-neutrophil cytoplasmic antibodies in propylthiouracil-induced lupus-like syndrome.

  2015cited by this paper
• The effect of cell death in the initiation of lupus nephritis

  2015cited by this paper
• Effect of blood pressure and glycemic control on the plasma cell-free DNA in hemodialysis patients

  2015cited by this paper
• Circulating Double-Stranded DNA in Plasma of Hemodialysis Patients and its Association with Iron Stores.

  2015cited by this paper
• Association between severe disease course and nephritis with Q222R polymorphism in DNAse I gene among lupus patients: An Argentine multicenter study.

  2015cited by this paper
• Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease

  2015cited by this paper
• Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients

  2015cited by this paper
• Effects of Nephrolithiasis on Serum DNase (Deoxyribonuclease I and II) Activity and E3 SUMO-Protein Ligase NSE2 (NSMCE2) in Malaysian Individuals.

  2015cited by this paper
• Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof‐of‐Concept Trial of Metformin

  2015cited by this paper
• The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis

  2015cited by this paper
• Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury

  2015cited by this paper
• Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury

  2015cited by this paper
• Cell‐free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma

  2015cited by this paper
• Admission Cell Free DNA as a Prognostic Factor in Burns: Quantification by Use of a Direct Rapid Fluorometric Technique

  2014cited by this paper
• Regulated cell death and inflammation: an auto-amplification loop causes organ failure

  2014cited by this paper
• High Cell-Free DNA Predicts Fatal Outcome among Staphylococcus aureus Bacteraemia Patients with Intensive Care Unit Treatment

  2014cited by this paper
• Use of Transrenal DNA for the Diagnosis of Extrapulmonary Tuberculosis in Children: a Case of Tubercular Otitis Media

  2014cited by this paper
• Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2

  2014cited by this paper
• Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise.

  2014cited by this paper
• Cooperation of Factor VII–Activating Protease and Serum DNase I in the Release of Nucleosomes From Necrotic Cells

  2014cited by this paper
• Preconditioning with Intravenous Colitic Cell-Free DNA Prevents DSS-Colitis by Altering TLR9-Associated Gene Expression Profile

  2014cited by this paper
• Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

  2014cited by this paper
• BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease

  2014cited by this paper
• Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis.

  2014cited by this paper
• Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification

  2014cited by this paper
• Extracellular histones in tissue injury and inflammation

  2014cited by this paper
• Recent advances in clinical applications of circulating cell-free DNA integrity.

  2014cited by this paper
• Impact of extracellular RNA on endothelial barrier function

  2014cited by this paper
• Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing

  2014cited by this paper
• Intrinsic Self-DNA Triggers Inflammatory Disease Dependent on STING

  2014cited by this paper
• Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection

  2014cited by this paper
• Role of Extracellular RNA in Atherosclerotic Plaque Formation in Mice

  2014cited by this paper
• Admission Cell Free DNA Levels Predict 28-Day Mortality in Patients with Severe Sepsis in Intensive Care

  2014cited by this paper
• Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats

  2013cited by this paper
• Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.

  2013cited by this paper
• Is plasma cell-free DNA really a useful marker for diagnosis and treatment of trauma patients?

  2013cited by this paper
• Quantification of Plasma Cell-Free DNA1 in Predicting Therapeutic Efficacy of Sorafenib on Metastatic Clear Cell Renal Cell Carcinoma

  2013cited by this paper
• Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis.

  2013cited by this paper
• Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen

  2013cited by this paper
• A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR.

  2013cited by this paper
• Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.

  2013cited by this paper
• Plasma Bacterial and Mitochondrial DNA Distinguish Bacterial Sepsis From Sterile Systemic Inflammatory Response Syndrome and Quantify Inflammatory Tissue Injury in Nonhuman Primates

  2013cited by this paper
• Characterization of the role of distinct plasma cell‐free DNA species in age‐associated inflammation and frailty

  2013cited by this paper
• Regulation of Neutrophil Extracellular Trap Formation by Anti-Inflammatory Drugs

  2013cited by this paper
• Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing

  2013cited by this paper
• High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing.

  2013cited by this paper
• A novel blood collection device stabilizes cell-free RNA in blood during sample shipping and storage

  2013cited by this paper
• Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.

  2013cited by this paper
• Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation

  2013cited by this paper
• Monitoring of Plasma Cell-Free DNA in Predicting Postoperative Recurrence of Clear Cell Renal Cell Carcinoma

  2013cited by this paper
• Circulating cell free DNA: Preanalytical considerations.

  2013cited by this paper
• Prognostic value of cell-free DNA in plasma of out-of-hospital cardiac arrest survivors at ICU admission and 24h post-admission.

  2013cited by this paper
• Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study

  2013cited by this paper
• Circulating cell-free DNA in hemodialysis patients predicts mortality.

  2012cited by this paper
• Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.

  2012cited by this paper
• Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients.

  2012cited by this paper
• A Genome-Wide Association Study Identifies UGT 1 A 1 as a Regulator of Serum Cell-Free DNA in Young Adults : The Cardiovascular Risk in Young Finns Study

  2012cited by this paper
• Alterations in methylation status of immune response genes promoters in cell-free DNA during a hemodialysis procedure

  2012cited by this paper
• Serum cell‐free DNA in renal cell carcinoma

  2012cited by this paper
• Influence of Temperature during Transportation on Cell-Free DNA Analysis

  2012cited by this paper
• Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury.

  2012cited by this paper
• Cell-free DNA as a measure of transplant injury.

  2012cited by this paper
• Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma

  2012cited by this paper
• Increased death of adipose cells, a path to release cell free DNA into systemic circulation of obese women

  2012cited by this paper
• Prognostic utility and characterization of cell-free DNA in patients with severe sepsis

  2012cited by this paper
• A Genome-Wide Association Study Identifies UGT1A1 as a Regulator of Serum Cell-Free DNA in Young Adults: The Cardiovascular Risk in Young Finns Study

  2012cited by this paper
• Stabilization of cell-free RNA in blood samples using a new collection device.

  2012cited by this paper
• Apoptotic cell-free DNA promotes inflammation in haemodialysis patients.

  2012cited by this paper
• Plasma Cell-Free DNA Levels Are Elevated in Acute Puumala Hantavirus Infection

  2012cited by this paper
• Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease

  2012cited by this paper
• Cell-Free DNA as a Marker for Prediction of Brain Damage in Traumatic Brain Injury in Rats

  2012cited by this paper
• Continuous adaptation through genetic communication – a putative role for cell-free DNA

  2012cited by this paper
• Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the Vitality 90+ Study.

  2012cited by this paper
• Circulating Cell-Free DNA

  2012cited by this paper

• Cell-free DNA in female infertility: from pathological mechanisms to clinical biomarkers.

  2026cites this paper
• Influence of microbiological characteristics of infections caused by Klebsiella pneumoniae on antibiotic resistance and severity of the infection process

  2025cites this paper
• DNA coronas resist nuclease degradation

  2025cites this paper
• Surface-Enhanced Raman Spectroscopy (SERS)-Based Chemometric Modelling for Chronic Renal Failure Using 50 kDa Ultra-Filtration

  2025cites this paper
• Early post-lung transplant cell-free DNA levels are associated with baseline lung allograft function.

  2025cites this paper
• Circulating cell‐free mitochondrial DNA in diabetes mellitus: Current insights and unexplored frontiers

  2025influential citation
• Repeatome Analysis of Plasma Circulating DNA in Patients with Cardiovascular Disease: Variation with Cell-Free DNA Integrity/Length and Clinical Parameters

  2025cites this paper
• Emerging Cell-Free DNA Scavenging Biomaterials for Inflammatory Diseases: From Mechanisms to Therapies.

  2025cites this paper
• The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases

  2025cites this paper
• Significance of neutrophil extracellular traps and low-density granulocytes in advanced chronic kidney disease (stage 5D) cases with COVID-19

  2025cites this paper
• Discrimination of urine infrared spectral biomarkers for early-stage chronic kidney disease patients using attenuated total reflectance fourier transform infrared spectrometry.

  2025cites this paper
• Perspectives on the utilization of cell-free DNA in amyotrophic lateral sclerosis (ALS) diagnostics and prognostics - insight from cancer research.

  2025cites this paper
• Cell-Free Genomic DNA Release into Serum of Wild Boar and Domestic Pigs Infected with Highly Virulent African Swine Fever Virus

  2025cites this paper
• Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy

  2025cites this paper
• Advances and challenges in the application of donor-derived cell-free DNA for diagnosis and treatment in liver transplantation: a narrative review

  2025cites this paper
• The role of renal and liver function in clinical ctDNA testing

  2025cites this paper
• Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders

  2025cites this paper
• Dynamics and Half-Life of Cell-Free DNA After Exercise: Insights from a Fragment Size-Specific Measurement Approach

  2025cites this paper
• Association between extracellular DNA levels, markers of inflammation and left ventricular mass index in children with chronic kidney disease

  2025cites this paper
• Effects of cell-free DNA on kidney disease and intervention strategies

  2024cites this paper
• The clinical utility of circulating tumor DNA in colorectal cancer: A narrative review

  2024cites this paper
• Targeted liquid biopsy for brain tumors

  2024cites this paper
• A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury

  2024cites this paper
• Association of corticosteroid therapy with reduced acute kidney injury and lower NET markers in severe COVID-19: an observational study

  2024cites this paper
• Application of graft-derived cell-free DNA for solid organ transplantation

  2024cites this paper
• Cell-Free DNA-Scavenging and Oxidative Stress-Interventing Nb2CTx MXene/WS2 Nanoflowers for Acute Kidney Injury Therapy

  2024cites this paper
• The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine

  2024cites this paper
• Cell-free DNA in patients with sepsis: long term trajectory and association with 28-day mortality and sepsis-associated acute kidney injury

  2024cites this paper
• Effects of blood-processing protocols on cell-free DNA fragmentomics in plasma: Comparisons of one- and two-step centrifugations.

  2024cites this paper
• The Role of Biomarkers in Diagnosis of Sepsis and Acute Kidney Injury

  2024influential citation
• DNA corona on nanoparticles leads to an enhanced immunostimulatory effect with implications for autoimmune diseases

  2024cites this paper
• Pre-Analytical Factors Affecting Extracellular DNA in Saliva

  2024cites this paper
• The role of dd-cfDNA in kidney transplantation: Is this the future of non-invasive kidney graft assessment?

  2023cites this paper
• What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?

  2023cites this paper
• Increased Presence of Circulating Cell-Free, Fragmented, Host DNA in Pigs Infected with Virulent African Swine Fever Virus

  2023influential citation
• Diagnostic liquid biopsy biomarkers in renal cell cancer

  2023cites this paper
• Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group, open-labelled non-inferiority randomised controlled trial in

  2023cites this paper
• Release of fragmented host, cell-free, genomic DNA into the circulation of pigs during infection by virulent African swine fever virus

  2023influential citation
• The role of neutrophils and neutrophil extracellular traps in renal diseases of bacterial origin

  2023cites this paper
• Three-week sprint interval training (SIT) reduces cell-free DNA and low-frequency fatigue but does not induce VO2max improvement in older men

  2023cites this paper
• Circulating Cell-Free DNA in Inflammatory Bowel Disease: Liquid Biopsies with Mechanistic and Translational Implications

  2023cites this paper
• Polyglycerol‐Amine Covered Nanosheets Target Cell‐Free DNA to Attenuate Acute Kidney Injury

  2023cites this paper
• Cyclic GMP–AMP Synthase (cGAS) Deletion Reduces Severity in Bilateral Nephrectomy Mice through Changes in Neutrophil Extracellular Traps and Mitochondrial Respiration

  2023cites this paper
• DNA in fresh urine supernatant is not affected by additional centrifugation and is protected against deoxyribonuclease.

  2023cites this paper
• The role of extracellular histones in COVID‐19

  2022cites this paper
• Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation

  2022cites this paper
• Emerging Role of Clinical Genetics in CKD

  2022cites this paper
• Dynamics of Plasma and Urinary Extracellular DNA in Acute Kidney Injury

  2022cites this paper
• Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancer.

  2022cites this paper
• Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.

  2022cites this paper
• The rising tide of cell-free DNA profiling: from snapshot to temporal genome analysis

  2022cites this paper
• Mini-review cell free DNA; diagnostic and prognostic approaches to oncology

  2022cites this paper
• The Influence of Proteins on Fate and Biological Role of Circulating DNA

  2022cites this paper
• Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis

  2022cites this paper
• Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation

  2022cites this paper
• New Perspectives on the Importance of Cell-Free DNA Biology

  2022cites this paper
• Extracellular DNA concentrations in various aetiologies of acute kidney injury

  2022cites this paper
• Reactive Oxygen Species- and Cell-Free DNA-Scavenging Mn3O4 Nanozymes for Acute Kidney Injury Therapy.

  2022cites this paper
• Understanding Donor-derived Cell-free DNA in Kidney Transplantation: An Overview and Case-based Guide for Clinicians

  2022cites this paper
• Laboratory Tests for Organ Transplant Rejection

  2022cites this paper
• Association of Perioperative Cell-free DNA (cfDNA) Concentrations with Risk of Recurrence in Patients with Breast Cancer

  2021cites this paper
• Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents.

  2021cites this paper
• EBV load is associated with cfDNA fragmentation and renal damage in SLE patients

  2021cites this paper
• A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation.

  2021cites this paper
• Circulating Free DNA and Its Emerging Role in Autoimmune Diseases

  2021cites this paper
• New Potential Biomarkers for Chronic Kidney Disease Management—A Review of the Literature

  2020cites this paper
• Donor-specific cell-free DNA as a biomarker in liver transplantation: A review

  2020cites this paper
• Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms

  2020cites this paper
• Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy

  2020cites this paper
• Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality

  2020cites this paper
• Ex Vivo Administration of Mesenchymal Stromal Cells in Kidney Grafts Against Ischemia Reperfusion Injury - Effective Delivery Without Kidney Function Improvement Posttransplant.

  2020cites this paper
• Finding new cancer epigenetic and genetic biomarkers from cell-free DNA by combining SALP-seq and machine learning

  2020cites this paper
• Plasma Concentrations of Extracellular DNA in Acute Kidney Injury

  2020cites this paper
• Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study

  2020cites this paper
• Serum cell-free DNA and progression of diabetic kidney disease: a prospective study

  2020cites this paper
• Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases.

  2020cites this paper
• Pregnancy on dialysis and with a failing kidney graft: A double challenge for non‐invasive prenatal testing

  2020cites this paper
• The Rebound of Early Post‐operative Plasma dd-cfDNA in Kidney Transplant Recipients: A Single‐center Study

  2020cites this paper
• Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy

  2020cites this paper
• Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.

  2019cites this paper
• Rejection Mechanisms and Bioindicators in Kidney Transplantation

  2019cites this paper
• Medical Policy Manual FEP 2 . 01 . 68 Laboratory Tests for Heart and Kidney Transplant Rejection Effective Policy Date : January 1 , 2020

  2019cites this paper
• Clinical relevance of cell-free mitochondrial DNA during the early postoperative period in kidney transplant recipients

  2019cites this paper
• Cell-free DNA as a Clinical Indicator in Maternal Blood

  2019cites this paper
• Noninvasive Urinary Monitoring of Progression in IgA Nephropathy

  2019cites this paper
• Analysis of serum cfDNA concentration and integrity before and after surgery in patients with lung cancer.

  2019cites this paper
• Cell-free tumor DNA: Emerging reality in oral squamous cell carcinoma

  2019cites this paper
• Introductory Chapter: Liquid Biopsy — A Promising Technology of the Future

  2019influential citation
• Extracellular DNA traps in inflammation, injury and healing

  2019cites this paper
• Life and death of circulating cell-free DNA

  2019cites this paper
• Advances in Detection of Kidney Transplant Injury

  2019cites this paper
• Cell Free DNA and CD38 Expression on T helper Cells as Biomarkers of Disease Activity in Rheumatoid Arthritis

  2018cites this paper
• Dynamics of early post‐operative plasma ddcfDNA levels in kidney transplantation: a single‐center pilot study

  2018cites this paper